Authors: Kote-Jarai, Z Easton, D Edwards, SM Jefferies, S Durocher, F Jackson, RA Singh, R Ardern-Jones, A Murkin, A Dearnaley, DP Shearer, R Kirby, R Houlston, R Eeles, R

Citation: Z. Kote-jarai et al., Relationship between glutathione S-transferase M1, P1 and T1 polymorphismsand early onset prostate cancer, PHARMACOGEN, 11(4), 2001, pp. 325-330

Authors: Singh, R Eeles, RA Durocher, F Simard, J Edwards, S Badzioch, M Kote-Jarai, Z Teare, D Ford, D Dearnaley, D Ardern-Jones, A Murkin, A Dowe, A Shearer, R Kelly, J Labrie, F Easton, D Narod, SA Tonin, PN Foulkes, WD

Citation: R. Singh et al., High risk genes predisposing to prostate cancer development - do they exist?, PROSTATE C, 3(4), 2000, pp. 241-247

Authors: Gayther, SA de Foy, EAF Harrington, P Pharoah, P Dunsmuir, WD Edwards, SM Gillett, C Ardern-Jones, A Dearnaley, DP Easton, DF Ford, D Shearer, RJ Kirby, RS Dowe, AL Kelly, J Stratton, MR Ponder, BAJ Barnes, D Eeles, RA

Citation: Sa. Gayther et al., The frequency of germ-line mutations in the breast cancer predisposition genes BRCA1 and BRCA2 in familial prostate cancer, CANCER RES, 60(16), 2000, pp. 4513-4518

Authors: Ardern-Jones, A Eeles, R

Citation: A. Ardern-jones et R. Eeles, Hereditary cancer, CANCER NURSING: CARE IN CONTEXT, 2000, pp. 297-312

Authors: Edwards, SM Badzioch, MD Minter, R Hamoudi, R Collins, N Ardern-Jones, A Dowe, A Osborne, S Kelly, J Shearer, R Easton, DF Saunders, GF Dearnaley, DP Eeles, RA

Citation: Sm. Edwards et al., Androgen receptor polymorphisms: Association with prostate cancer risk, relapse and overall survival, INT J CANC, 84(5), 1999, pp. 458-465